DURACLON patient counseling information: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Clonidine}} {{CMG}}; {{AE}} {{PB}} '''''For patient information, click here'''''. ==Patient Counseling Information== {{Cite ...") |
No edit summary |
||
| Line 6: | Line 6: | ||
==Patient Counseling Information== | ==Patient Counseling Information== | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638#i4i_clinical_pharmacology_id_a61d4026-7aae-4211-9bb5-332675db4e46 | publisher = | date = | accessdate = 6 February 2014 }}</ref> | |||
{{Cite web | last = | first = | title = DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638 | publisher = | date = | accessdate = | |||
Revision as of 16:50, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information, click here.
Patient Counseling Information
References
- ↑ "DURACLON (CLONIDINE HYDROCHLORIDE) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]". Retrieved 6 February 2014.